Cytokines such as interferons (IFNs) activate signal transducers and activators of transcription (STATs) via phosphorylation. Histone deacetylases (HDACs) and the histone acetyltransferase (HAT) CBP dynamically regulate STAT1 acetylation. Here we show that acetylation of STAT1 counteracts IFN-induced STAT1 phosphorylation, nuclear translocation, DNA binding, and target gene expression. Biochemical and genetic experiments altering the HAT/HDAC activity ratio and STAT1 mutants reveal that a phospho-acetyl switch regulates STAT1 signaling via CBP, HDAC3, and the T-cell protein tyrosine phosphatase (TCP45). Strikingly, inhibition of STAT1 signaling via CBP-mediated acetylation is distinct from the functions of this HAT in transcriptional activation. STAT1 acetylation induces binding of TCP45, which catalyzes dephosphorylation and latency of STAT1. Our results provide a deeper understanding of the modulation of STAT1 activity. These findings reveal a new layer of physiologically relevant STAT1 regulation and suggest that a previously unidentified balance between phosphorylation and acetylation affects cytokine signaling.
The STAT signaling pathway is a paradigm for ligandinduced signaling from the cell surface to the nucleus. Cytokines and growth factors activate the transcription factor STAT1, which regulates the expression of physiologically important genes for cell growth, differentiation, apoptosis, and immune functions. Interferons (IFNs) are cytokines that induce dimerization of their cognate receptors leading to phosphorylation-dependent activation of the receptor-associated tyrosine kinases JAK1/2 and TYK2. These phosphorylate the C-terminal tyrosine residues Y 701 in STAT1 and Y 690 in STAT2. Subsequently, STAT1 homodimers or STAT1/STAT2 heterodimers reciprocally interacting via their Src homology 2 (SH2) domains rapidly accumulate in the nucleus and induce STAT1 target genes (Ihle 2001; Platanias 2005; Stark 2007) .
Receptor internalization, decreased kinase activity, and sumoylation of STAT1, SOCS, and PIAS proteins; as well as STAT1 dephosphorylation by phosphatases (PTPs) followed by nuclear export counteract in vivo responses to IFN (Lim and Cao 2006; Kim and Lee 2007) . The PTP Tcell protein tyrosine phosphatase (TCP45) dephosphorylates nuclear STAT1, which recycles STAT1 back to the cytoplasm (ten Hoeve et al. 2002) . TCP45 additionally provides latency to previously activated STAT1 independent of the kinase and receptor status in vivo (Sakamoto et al. 2004b ). However, the ''timer'' setting inactivation of phosphorylated nuclear STAT1 remains an enigma.
External as well as internal signals can induce the association of substrates with histone acetyltransferases (HATs) and histone deacetylases (HDACs) controlling the specificity and level of acetylation-dependent protein functions. Acetylation of histones mediated by HATs is a prerequisite for STAT1-dependent transcription (Paulson et al. 2002; Kouzarides 2007) . Phosphorylated, nuclear STAT1 transiently binds the HAT CBP (Zhang et al. 1996) , which can exist in a complex with the coactivator p/CIP. CBP cannot compensate a lack of p/CIP, which makes it difficult to define individual roles of these factors (Torchia et al. 1997 ). Recent data demonstrate that association of CBP with STAT1 and acetylation of histones at STAT1 target genes are temporally separated processes (Christova et al. 2007 ; Ramsauer et al. 2007 ).
Strikingly, STAT1-CBP complex formation can even correlate with reduced histone acetylation (Nusinzon and Horvath 2003) . Moreover, a STAT1 mutant that is unable to recruit CBP to chromatin still supports IFNdependent transcription (Ramsauer et al. 2007 ). In agreement with such findings, IFN-dependent activation of STAT1 target genes requires GCN5 rather than CBP/p300 (Paulson et al. 2002) .
Apart from tyrosine-phosphorylation, other functionally important post-translational modifications of STAT1 were identified (Lim and Cao 2006; Kim and Lee 2007) . Recently, we described that CBP-mediated acetylation of STAT1 depends on the e-amino group of lysine residues K 410 and K 413 (Krä mer et al. 2006) , which belong to the surface-exposed DNA-binding domain (DBD) common to all STATs. Dynamic acetylation of STAT1 is consistent with its interaction with both, HATs and HDACs. Remarkably, data from biochemical and genetic experiments show that HDAC activity is necessary for IFNinduced STAT1 activation (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Zupkovitz et al. 2006; Vlasá ková et al. 2007 ). However, it is not clear whether HDACs and HDAC inhibitors (HDACis) affect STAT1 activity directly or by modulating other factors involved in STAT1 signaling.
Here we provide a mechanistic basis for the negative role of STAT1 acetylation in cytokine signaling. Following rapid activation of STAT1 via IFN, acetylation of STAT1 sets the timer for STAT1 inactivation via complex formation between acetylated STAT1 and the PTP TCP45. HDAC3 deacetylates STAT1, thus permitting phosphorylation and restimulation. Reversible, dynamic acetylation hence switches STAT1 between different functional modes. Our data provide novel insights into the covalent modification cycle, which limits the duration of the cytokine signal.
Results

Acetylation of STAT1 inhibits IFN-dependent STAT1 phosphorylation and nuclear translocation
IFNs can induce phosphorylation as well as acetylation of STAT1 in vitro and in vivo (Krä mer et al. 2006; Hayashi et al. 2007; Tang et al. 2007 ). We examined the kinetics of STAT1 phosphorylation and acetylation in 293T cells treated with the type I interferon IFNa. Our data demonstrate that STAT1 acetylation follows STAT1 phosphorylation, and we found a correlation between STAT1 acetylation and dephosphorylation (Fig. 1A) . Furthermore, using stringent immunoprecipitation (IP) conditions, we noted that acetylation and phosphorylation can transiently occur simultaneously on STAT1 (Fig. 1B) . To evaluate the functional consequences of STAT1 acetylation, we analyzed whether a previous exposure to IFNa affects STAT1 phosphorylation. We found that, independent of ongoing protein synthesis or degradation and irrespective of the type of IFN and its cognate receptor, STAT1 could not be phosphorylated in re-exposed cells ( Fig. 1C,D; Supplemental Fig. S1A ), which confirms previous observations (Sakamoto et al. 2004a) . If STAT1 acetylation contributes to this process, HDACis should equally prevent STAT1 phosphorylation. Indeed, consistent with a previous report (Klampfer et al. 2004) , pretreatment with HDACis inhibited IFNa-or IFNg-induced STAT1 phosphorylation in 293T, SK-Mel-37, and 2fTGH cells ( Fig. 1E ; data not shown). We could confirm such results in the presence of a caspase inhibitor or with MCF7 cells resistant to apoptosis induced by HDACis (Supplemental Fig. S1B,C ; Krä mer et al. 2008a ). Thus, acetylation-dependent inactivation of STAT1 occurs independently of apoptosis. Furthermore, in agreement with the slow kinetics of HDACi-induced STAT1 acetylation (Krä mer et al. 2006) , coadministration of HDACi and IFN did not affect the extremely rapid IFN-induced phosphorylation of STAT1 (Fig. 1F ), but accelerated its dephosphorylation. Delayed acetylation of STAT1 in the absence of IFN presumably stems from very low levels of nuclear STAT1 able to interact with CBP residing in the nucleus (Zhang et al. 1996; Meyer et al. 2003; Krä mer et al. 2006) . Consistently, short-term incubation with IFNa did not evoke STAT1 acetylation (Supplemental Fig.  S1D ). STAT1 acetylation correlates with its nuclear shuttling and time-delayed cytoplasmic accumulation of CBP (Krä mer et al. 2006 , bound Importin a5 (Fig. 1I ) mediating nuclear transport of phosphorylated STAT1 (Sekimoto et al. 1997; Melé n et al. 2001) .
STAT1 DNA-binding mutants do not accumulate in the nucleus because of their rapid export via a leptomycin B (LMB)-sensitive CRM1-dependent mechanism (Meyer et al. 2003) . We tested the effect of LMB on nuclear accumulation of STAT1. Whereas wild-type STAT1 was retained in the nucleus after stimulation with IFN and LMB, no increase of STAT1 K410,413Q in the nucleus was detectable under such conditions (Supplemental Fig.  S1G ). Hence, upstream events such as decreased phosphorylation appear responsible for the latency of pseudoacetylated STAT1. The resistance of acetylated STAT1 to IFNa is unlikely to be caused by decreased interactions with the IFNa receptor (IFNAR) or kinases, since wildtype STAT1 and STAT1 K410,413Q equally colocalized with these factors, and both coprecipitated with the IFNAR (Fig. 1J,K with CBP could prevent acetylation of STAT1 K410,413R , we performed a pull-down experiment to demonstrate direct interactions of these proteins (Zhang et al. 1996) . Both STAT1 variants equally bound to fragments of CBP containing the two reported STAT1-CBP contact regions (Fig. 1N ). These findings strongly indicate that acetylation of STAT1 (likely at lysines K 410 and/or K
413
) critically counteracts cytokine-induced STAT1 activation.
Acetylation of STAT1 inhibits IFN-induced STAT1-dependent gene expression
HDACis have been reported to counteract STAT1 signaling (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Vlasá ková et al. 2007 ). To gain insights into the underlying molecular mechanism, we transfected U3A cells with vectors for STAT1 or K 410 , K 413 mutants and a GAS-luciferase reporter plasmid harboring promoter elements of IFNaresponsive STAT1 target genes subject to induction by an activated STAT1 homodimer (Torchia et al. 1997; Platanias 2005) . Wild-type STAT1 potently activated this reporter after IFNa stimulation. STAT1 K410,413R activated IFN-dependent transcription even more robustly, whereas STAT1 K410,413Q failed to induce reporter activity ( Fig. 2A) . By quantitative real-time PCR, we determined the expression of the IFNa-induced, endogenous STAT1 target genes isg15 and ubcH8 in U3A cells stably transfected with vectors for STAT1. ISG15 and UBCH8 play important roles in the immune response and in several cancers (Dao and Zhang 2005; Krä mer et al. 2008b; Okumura et al. 2008) , and these genes are induced by an activated STAT1/STAT2 homodimer binding to an ISRE sequence , and STAT1 K413Q after IFN stimulation. (Nyman et al. 2000; Pfeffer et al. 2004) . IFNa strongly enhanced the expression of both genes in STAT1-positive cells. STAT1 K410,413R induced isg15 and ubcH8 even more potently than wild-type STAT1, while STAT1 K410,413Q was unable to mediate significant induction of these genes (Fig. 2B) . Western blot analyses showed that this also translates into corresponding UBCH8 protein levels in U3A cells (Fig. 2C) .
Next, we assessed STAT1-DNA complex formation with a GAS consensus oligonucleotide (Meyer et al. 2003) . Both STAT1 and STAT1 K410,413R bound this DNA element upon IFN stimulation ( Fig. 2D; Supplemental  Fig. S1H ). Consistent with all our observations that STAT1 K410,413Q is resistant to IFNa, this protein was not recovered with the GAS sequence. To dissect potential site-specific effects, we used STAT1 mutants harboring single K-to-Q exchanges (Supplemental Fig. S1E Fig. 2E-I) .
Moreover, in 293T cells, phosphorylation of endogenous STAT1 is suppressed by STAT1 K410,413Q in trans (Fig.  3A) . U3A cells restored with STAT1 and STAT1 K410,413Q recapitulate this finding, as the latter prevents phosphorylation of the wild type (Fig. 3B) . Consistent with these data, STAT1 K410,413Q , STAT1 K410Q , STAT1 K413Q , or HDACi treatment inhibited nuclear signaling and DNA binding of endogenous STAT1 ( Fig. 3C-G ; data not shown). Our findings indicate that acetylated STAT1 inhibits activation of nonacetylated STAT1 in trans.
Increasing evidence indicates that acetylation negatively affects IFN-induced STAT signaling (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Zupkovitz et al. 2006; Vlasá ková et al. 2007 ). Therefore, we asked if our mutant mimicking nonacetylated STAT1 (Fig. 1M ) is resistant to HDACi-induced inactivation. We reconstituted U3A cells with wild-type STAT1 and STAT1 K410,413R and treated these cells with IFNa and VPA. As expected, signaling by wild-type STAT1 was inhibited by acetylation. Expression of ISG15 was inhibited more strongly than UBCH8, which likely results from a complex mechanism by which HDACis induce expression of UBCH8, but not of ISG15 (Krä mer et al. 2003 ; data not shown). In sharp contrast, signaling by STAT1 K410,413R was significantly induced upon inhibition of HDACs (Fig. 3H ). These data demonstrate that acetylation per se can promote IFN-induced signaling, whereas acetylation of STAT1 counteracts this process.
Independent of stimulation with IFN, STAT1 dimerizes with other STAT1 or STAT2 molecules (Gupta et al. 1996; Stancato et al. 1996; Braunstein et al. 2003; Mao et al. 2005; Mertens et al. 2006 K410,413R interacted equally well with Flagtagged STAT1 and with endogenous STAT2, independent of K-to-Q mutations in the STAT1 DBD (Fig. 3I-K) . Besides being congruent with the observation that HDACis do not affect STAT1 dimerization (Nusinzon and Horvath 2003) , our data indicate that the unresponsiveness of acetylated STAT1 and STAT1 K410,413Q to IFN is not just due to a defect in dimerization.
Considering these results and colocalization of STAT1 K410,413Q with STAT2 shown by confocal microscopy (Fig.  3L) , we examined whether STAT1 K410,413Q inhibits STAT2 phosphorylation in trans. IFNa still induced STAT2 phosphorylation in the presence of STAT1 K410,413Q (Fig. 3M ), demonstrating that mimicking acetylation of STAT1 at these lysine residues inactivates specifically STAT1.
A recent report shows acetylation of STAT3 at K 685 (Yuan et al. 2005) corresponding to K 679 in STAT1 (Supplemental Fig. S1I ). Acetylation of STAT1 at this site in principle could impair STAT1 signaling. However, we observed no differences in phosphorylation levels of wildtype STAT1 and STAT1 K679Q (Fig. 3N) . Hence, mimicking acetylation of STAT1 at K 410 and K 413 very specifically counteracts STAT1 signaling.
STAT1 activity is regulated by CBP and GCN5
Previously, we found that CBP is the HAT responsible for acetylation of STAT1, and that CBP translocates to the cytoplasm in response to IFN-a or HDACi (Krä mer et al. 2006) . The slow kinetics of HDACi-induced, compared with IFN-induced, acetylation of STAT1 correlates with delayed cytosolic appearance of CBP (data not shown). Since CBP specifically acetylates STAT1 (Krä mer et al. 2006; Tang et al. 2007 ), we asked whether this HAT contributes to the termination of STAT1 signaling. Positive effects of cytosolic CBP/p300 on STAT signaling at the level of the IFNAR were observed in overexpression systems (Tang et al. 2007 ). This study, however, did not analyze the effect of STAT1 acetylation on IFN-induced signaling, and numerous reports clearly demonstrate that HDAC activity is required for IFN-induced STAT1 activation (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Zupkovitz et al. 2006; Vlasá ková et al. 2007 ). Because unphysiological overexpression of the global regulator CBP cannot distinguish between artificially increased basal expression and IFN-induced expression of STAT1 target genes (O'Shea et al. 2005; Lim and Cao 2006) , we used RNAi to analyze the role of CBP in STAT1 signaling induced by the physiological stimulus IFN. We generated 293T cells stably expressing shRNAs targeting CBP. Our data demonstrate that silencing of CBP significantly attenuated STAT1 dephosphorylation (Fig. 4A) . Accordingly, reporter gene assays and analyses of endogenous ISG15 and UBCH8 levels showed enhanced IFNa-triggered STAT1-dependent transcription in cells with reduced CBP expression (Fig. 4B-D) . These data are consistent with specific acetylation of STAT1 by CBP and enhanced IFN-induced signaling via nonacetylatable STAT1 (Figs.  1M, 2A-C, 3H ).
GCN5 catalyzes the acetylation of histones, but not of STAT1 (Paulson et al. 2002; Kouzarides 2007; Tang et al. 2007) . We therefore analyzed the function of this HAT in IFN-induced signaling via an siRNA approach. This experiment showed that ablation of GCN5 decreased the induction of the GAS-reporter and of endogenous UBCH8 (Fig. 4E,F) . Degradation or nuclear export of GCN5 cannot, however, explain why HDACi or pretreatment with IFNa inhibit STAT1 signaling, as GCN5 remained stable and nuclear under these conditions (Supplemental Fig. S2A ). Our data demonstrate opposing effects of CBP and GCN5 on IFN-dependent STAT1 signaling. In contrast to GCN5, CBP can negatively regulate STAT1 activity in this context.
HDAC3 catalyzes STAT1 deacetylation
VPA, which selectively inhibits the class I HDACs HDAC1, HDAC2, HDAC3, and HDAC8, induces STAT1 acetylation (Gö ttlicher et al. 2001; Krä mer et al. 2006) . These HDACs are therefore likely candidate deacetylases for STAT1. In co-IP experiments with endogenous proteins from 293T cells, STAT1 was recovered in a complex with HDAC1 and HDAC3 ( Fig. 4G ; Krä mer et al. 2006) . In contrast to HDAC1, HDAC3 localizes to both, nucleus and cytoplasm, and interacts with STAT1 in both cellular compartments ( Fig. 4H ; Chang et al. 2004 ; data not shown). Thus, HDAC3 is the most likely STAT1 deacetylase in the cytosol initiating STAT1 signaling.
Cotransfection experiments confirmed that HDAC3 strongly counteracts CBP-mediated STAT1 acetylation (Fig. 4I) . Likewise, siRNA-induced ablation of HDAC3, similar to CBP overexpression, promoted STAT1 acetylation (Fig. 4J) . Remarkably, knocking down HDAC3 equally translated into reduced STAT1 phosphorylation and attenuated IFN-dependent transcriptional activation (Fig. 4K,L) . Hence, HDAC3 antagonizes STAT1 acetylation, which allows IFN-triggered STAT1 signaling. These observations provide an explanation why cytokine-induced STAT1 target gene expression requires HDAC activity. Our data further reveal that CBP and HDAC3 are the enzymes antagonistically regulating acetylation and ultimately signaling of STAT1.
PTP-dependent inactivation of acetylated STAT1
Activation by kinase-mediated phosphorylation and attenuation by PTP-mediated dephosphorylation are hallmarks of STAT1 signaling. We noted significant differences in the phosphorylation of STAT1 and STAT1 K410,413Q in vitro and in cells. Although TYK2 catalyzed phosphorylation of both proteins in vitro (Fig.  5A) , only wild-type STAT1 was phosphorylated in TYK2-transfected U3A cells (Fig. 5B) . Notably, application of the general PTP inhibitor vanadate together with IFNa not only maintained phosphorylation of endogenous STAT1 in 293T cells (Supplemental Fig. S2B ), but also permitted phosphorylation and nuclear translocation of STAT1 K410,413Q in U3A and 293T cells ( Fig. 5C,D ; Supplemental Fig. S2C ). In response to this treatment, STAT1 K410,413Q even induced endogenous UBCH8 and bound cognate DNA (Fig. 5E,F; Supplemental Fig. S2D ). Hence, PTPs antagonize kinase activity and appear to critically mediate STAT1's acetylation-dependent repression.
Since acetylated STAT1 forms a cytosolic complex with NFkB p65 in vitro and in vivo (Krä mer et al. 2006; Hayashi et al. 2007 ), NFkB and IkBs could attenuate STAT1 K410,413Q . However, STAT1 K410,413Q remained unresponsive to IFN upon inactivation of p65 by siRNAs or attenuation of IkBs by TNFa ( Fig. 5D,E; Supplemental  Fig. S3A ). These results, along with the observation that STAT1 K410,413Q and STAT1 interacted equally well with PIAS1, SOCS1, and SUMO1 (Supplemental Fig. S3B ), disfavor alternative PTP-independent regulatory mechanisms.
In agreement with these data, STAT1 acetylated via HDACi treatment was phosphorylated and bound to DNA after treatment with IFNa and vanadate (Fig. 5G) . Likewise, combined application of these stimuli induced phosphorylation of STAT1 K410Q and STAT1 K413Q in U3A cells. Both proteins could then bind GAS DNA as well as GCN5 and induce transcriptional activation ( Fig 
TCP45 binds to acetylated STAT1
We next investigated which PTPs are relevant for the inactivation of STAT1 following acetylation. SHP2 (SH2-containing PTP) and TCP45 are PTPs negatively regulating STAT1 signaling (ten Hoeve et al. 2002; Wu et al. 2002) . To clarify their role in the STAT1 phospho-acetyl switch, we generated 293T cells in which PTP levels are stably suppressed by shRNAs. Reporter assays with these cells confirmed that SHP2 and, even more potently, TCP45 suppress endogenous STAT1 signaling (Fig. 6A) . IFN-induced reporter gene activation was furthermore unaffected by vanadate treatment in cells bearing shRNAs against SHP2 and TCP45 (data not shown), which supports the view that they are the key PTPs for STAT1.
Since, similar to vanadate treatment, the down-regulation of TCP45 by shRNA rescued STAT1 signaling in the presence of STAT1 K410,413Q (Fig. 6B) , we focused on this PTP. If TCP45 prevents IFNa-induced phosphorylation of acetylated STAT1, HDACis should not inhibit STAT1 activation in 293T cells with reduced TCP45 levels. Indeed, STAT1 phosphorylation and DNA recognition were unaffected by HDACis in such cells (Fig. 6C) . Likewise, IFNa induced phosphorylation and strong nuclear accumulation of wild-type STAT1 and STAT1 K410,413Q in TCP45-depleted U3A cells ( Fig. 6D; Supplemental Fig.  S3C ). In U3A shTCP45 cells, STAT1 K410,413Q -activated transcription of endogenous STAT1 target genes ( 6E). The knockdown of this PTP equally rendered STAT1 K410Q and STAT1 K413Q responsive to IFNa (Fig.  6F) , which triggered transcriptional activation of STAT1 target genes (Fig. 6G,H) .
Importantly, co-IP analyses showed that STAT1 mutants mimicking acetylation of K 410,413 efficiently bound TCP45 (Fig. 7A) . This finding provides a rationale for the unresponsiveness of previously activated, acetylated STAT1 to IFN. Therefore, we studied by immunofluorescence whether IFNa not only induces acetylation of STAT1, but also affects the localization of endogenous TCP45 in intact cells. Indeed, periods of IFNa treatment inducing STAT1 acetylation (Fig. 1A,M) caused colocalization of TCP45 and STAT1, together with cytoplasmic translocation of this PTP ( Fig. 7B; Supplemental Fig. S3D ). Co-IP analyses further confirmed that STAT1 acetylation via IFNa induces formation of a complex containing STAT1 and TCP45 (Figs.1A, 7C) .
Further analyses showed that STAT1 phosphorylation peaks at ;20 min and starts to cease at ;40 min of IFN-a treatment. Consistent with the reported nuclear dephosphorylation of STAT1 (Haspel et al. 1996; Haspel and Darnell 1999; ten Hoeve et al. 2002) , LMB did not alter this kinetic (Fig. 7D) . We performed IP experiments with timed cytosolic and nuclear fractions to analyze the interaction of acetylated STAT1 and TCP45. Data obtained with this approach demonstrate that beginning dephosphorylation of STAT1 correlates with acetylated STAT1 binding to TCP45 in the nucleus. Additionally, there is a time-dependent accumulation of cytosolic TCP45 in a complex with acetylated STAT1 (Fig. 7E) .
Finally, we asked for how long acetylation of STAT1 inhibits IFN-induced signaling. For this purpose, we pulsed cells with IFN and chased them to study their ability to reinduce STAT1 phosphorylation. After a chase time of 2 h, we could clearly detect phosphorylated STAT1 (Fig. 7F) . Remarkably, the return of STAT1 to restimulation capacity was associated with decreased STAT1 acetylation, loss of CBP binding, and reassociation with HDAC3 (Fig. 7G) .
Our interaction studies and functional analyses demonstrate the dynamic regulation of STAT1 via CBP, HDAC3, and TCP45. Hence, these factors are key elements of a phospho-acetyl switch regulating STAT1 activity (Fig. 7H ).
Discussion
The molecular mechanisms responsible for STAT acetylation are under intense investigation, and IFN-dependent signaling via STAT1 is a paradigm for a pathway requiring deacetylase activity. We analyzed STAT1 signaling in vitro and in cells using a wide variety of conditions and methods. Our data indicate that a functional phospho-acetyl switch, regulated by an acetylation/deacetylation balance, modulates STAT1 signaling.
We initially reported that acetylated STAT1 inhibits NFkB (Krä mer et al. 2006) . Now, we demonstrate that acetylation of STAT1 counteracts its own activity. Our findings provide a mechanistic basis for the suspected negative role of acetylation on IFN-dependent signaling (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Zupkovitz et al. 2006; Vlasá ková et al. 2007) .
Both phosphorylation and acetylation are versatile modulators of protein functions and interactions (Schreiber and Bernstein 2002) . Cross-talk between serine phosphorylation and lysine methylation has been described for the kinetochore protein DAM1 and the transcription factor p53 (Fischle et al. 2003; Zhang and Dent 2005) . Our data identify STAT1 as a signaling molecule subject to an unexpected cross-regulation between phosphorylation and lysine acetylation. IFNinduced phosphorylation promotes nuclear translocation of STAT1, which enables it to interact with the acetyltransferase CBP. Acetylation of STAT1 by CBP correlates with the formation of a STAT1-TCP45 complex, dephosphorylation, and latency of STAT1. We conclude that the highly active PTP TCP45 acts as a ''transmission control protein'' docking to and inhibiting previously activated STAT1. STAT1 acetylation hence conveys information terminating stimulation and regulating restimulation.
Extensive conformational changes are necessary for STAT1 dephosphorylation. The ''pocket'' residues Q 340 , Q 408 , and G 384 are required for spatial reorientation of a parallel to an anti-parallel STAT1 dimer presenting the pY 701 to TCP45 (Zhong et al. 2005; Mertens et al. 2006 ). It appears feasible that after initial activation, and once acetylated in the nucleus by CBP, STAT1 is stabilized in its anti-parallel structure providing access for TCP45. Since HDACis inhibit IFN-induced phosphorylation and promote dephosphorylation of STAT1, acetylation of lysines K 410 and K 413 may facilitate both, disengagement of STAT1 from DNA and presentation to TCP45 (Meyer et al. 2003; Mao et al. 2005; Mertens et al. 2006) . Although K 410 and K 413 provide contacts of STAT1 with the DNA backbone Melé n et al. 2001) , these lysines do not contribute to specific STAT1-DNA contacts, and 12 additional amino acid side chains connect STAT1 with DNA Melé n et al. 2001) . In agreement with this, phosphorylated STAT1 K410,413Q can bind DNA, albeit slightly weaker than the wild type. Consistent with the observation that these residues do not belong to the ''pocket'' residues required for N-terminal dimerization, mutagenesis of K 410 , K 413 does not affect STAT1 dimerization. Furthermore, the activity of STAT1 K410,413Q under conditions in which TCP45 is blocked either by shRNA or vanadate strongly indicates that this protein is structurally intact.
Acetylation of STAT1 within its surface-exposed DBD determines functionally relevant interactions of STAT1 with other regulators of signaling. Since HATs interact with all STATs, acetylation and deacetylation might regulate each of them. Nevertheless, assessing the specific consequences of acetylation requires individual analyses. In the case of STAT1, acetylation clearly acts inhibitorily. In contrast, acetylation seems to affect STAT3 dimerization, and it remains to be determined how STAT3 signaling is terminated (Yuan et al. 2005) . Acetylation of STAT3 residues corresponding to K 410 and K 413 in STAT1 can be ruled out, as these residues are arginines in STAT3 (Supplemental Fig. S3E ), which could well explain why HDACis do not inhibit STAT3. Moreover, the fact that STAT1 acetylation does not suppress STAT2 function is consistent with the observation that STAT2 is inactivated neither by TCP45 nor by HDACis (Sakamoto et al. 2004b; Vlasá ková et al. 2007 ).
Equal to phosphorylation, acetylation does not necessarily enhance gene activation, and the physiological consequences of histone versus nonhistone protein modification by HATs and HDACs are clearly different (Schreiber and Bernstein 2002; Yang 2004 ). Reminiscent of data collected for STAT2 (Paulson et al. 2002) , our results support that GCN5 is required for IFN-induced STAT1/STAT2 signaling. In contrast to CBP, GCN5 catalyzes the acetylation of histones, but not of STAT1 (Paulson et al. 2002; Tang et al. 2007 ). In agreement with this finding, HDACis promote IFN-induced signaling, but only if IFN-dependent gene induction is evoked by a nonacetylatable STAT1 molecule. CBP and GCN5 even show opposing effects, as CBP-mediated acetylation of STAT1 within its DBD is dominant over STAT1 activation. Our results provide a rationale for the negative role of STAT1 acetylation on IFN signaling. They elucidate a novel, specific role of CBP, which is increasingly appreciated as a nonhistone protein acetyltransferase and a negative regulator of gene expression (Munshi et al. 1998; Zhang and Dent 2005) . In agreement with several studies (Nusinzon and Horvath 2003; Chang et al. 2004; Klampfer et al. 2004; Sakamoto et al. 2004a; Zupkovitz et al. 2006; Vlasá ková et al. 2007 ), our data demonstrate that CBP induces STAT1 acetylation and suppresses IFNdependent activation. Therefore, acetylation of STAT1 via CBP dominantly restricts the duration of IFN signaling in human cells responsive to this cytokine.
A very attractive hypothesis is that STAT1 acetylation acts as a ''memory mark'' designating previously activated STAT1. Within a ''STAT1 modification code,'' TCP45 apparently reads out acetylation of this transcription factor. Feed-forward mechanisms for STAT1 acetylation promoting association with TCP45 might be established by the CBP bromodomain recognizing N e -acetylated proteins, the IFN-induced cytosolic translocation of CBP, and the reduced interaction of acetylated STAT1 with HDACs (Yang 2004; Krä mer et al. 2006; Tang et al. 2007 ). In addition, dephosphorylated antiparallel STAT1 dimers remain intact and exit to the cytoplasm, tethered via their N-terminal domains (Mertens et al. 2006 ). Upon nuclear export, dimers or even oligomers of STAT1 (Gupta et al. 1996; Stancato et al. 1996; Vinkemeier and Meyer 2005; Mertens et al. 2006 ) within a complex containing even a limited number of acetylated STAT1 molecules, bound to CBP and TCP45, can counteract activation of the STAT1 pool. Via such a mechanism, unnecessary activation, energyconsuming degradation, and a potential loss of cytoplasmic functions of STAT1 is prevented (Krä mer et al. 2006; Lim and Cao 2006; Kim and Lee 2007) . Termination of STAT1 acetylation, via dissociation of CBP and association of HDAC3, in turn shifts the balance to permissiveness for restimulation. Deacetylation of STAT1 by HDACs may provide a molecular switch to restore inducible STAT1 in the cytoplasm, which would close the cycle of STAT1 activation and inactivation (Fig. 7H ). Such precise and dynamic acetylation/deacetylation-dependent regulatory circuits may have evolved to adjust cytokine-induced gene expression rapidly and economically in vivo.
In addition, both transcription factors, STAT1 as well as NFkB, induce inflammatory mediators contributing to inflammatory diseases, such as rheumatoid arthritis or Crohn's disease, STAT1 acetylation may hence be a central mechanism by which HDACis ameliorate pathophysiological settings with repeatedly released large amounts of proinflammatory cytokines (Blanchard and Chipoy 2005) .
Materials and methods
Cell lines, transfections, microscopy, drugs, and chemicals Cells were maintained as described (Krä mer et al. 2003 (Krä mer et al. , 2006 . Transfections were done with PEI (Sigma, for 293T) or Lipofectamine (Invitrogen; as recommended). Unless stated otherwise, 1 mg DNA/12-well or 5 mg DNA/10-cm plate were transfected, and cells were harvested 48 h later. Stable cell lines were generated with G418 (500 mg/mL) or Puromycin (2 mg/mL). 
